Concepedia

Willy Hugo

WH

39

Publications

12.3K

Citations

28

H-Index

2006

Active since

Affiliations

University of California, Los Angeles(Current)

UCLA Jonsson Comprehensive Cancer Center

Parker Institute for Cancer Immunotherapy

National University of Singapore

The University of Sydney

Willy Hugo is an author at University of California, Los Angeles specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2006–2024

39

Publications

39

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

Jesse M. Zaretsky, Ángel García-Díaz, Daniel Sanghoon Shin et al. · New England Journal of Medicine · 2016 · 3.1K citations · Full text

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

Ángel García-Díaz, Daniel Sanghoon Shin, Blanca Homet Moreno et al. · Cell Reports · 2017 · 1.8K citations · Full text

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla et al. · Nature Medicine · 2019 · 1.3K citations

, , +14

Primary Resistance to PD-1 Blockade Mediated by <i>JAK1/2</i> Mutations

Daniel Sanghoon Shin, Jesse M. Zaretsky, Helena Escuin-Ordinas et al. · Cancer Discovery · 2016 · 1.2K citations · Full text

Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy

Hubing Shi, Willy Hugo, Xiangju Kong et al. · Cancer Discovery · 2013 · 979 citations · Full text

Rows per page

1–5 of 39